Results 141 to 150 of about 125,156 (180)
Some of the next articles are maybe not open access.
2017
Sažeti prikaz nastanka, kliničke slike, dijagnosticiranja i liječenja medularnog karcinoma štitne žlijezde.
Kusić, Zvonko +7 more
openaire +1 more source
Sažeti prikaz nastanka, kliničke slike, dijagnosticiranja i liječenja medularnog karcinoma štitne žlijezde.
Kusić, Zvonko +7 more
openaire +1 more source
2019
Medullary thyroid cancer is very rare since it represents about 0.2% of all human tumors. It can be sporadic (75%) or familial (25%), and in both cases the pathogenesis is related to the presence of activating mutations of RET oncogene at somatic or germline level, respectively.
Rossella Elisei, Cristina Romei
openaire +1 more source
Medullary thyroid cancer is very rare since it represents about 0.2% of all human tumors. It can be sporadic (75%) or familial (25%), and in both cases the pathogenesis is related to the presence of activating mutations of RET oncogene at somatic or germline level, respectively.
Rossella Elisei, Cristina Romei
openaire +1 more source
Medullary Cancer of the Breast
2014Medullary carcinoma of the breast accounts for 2–7 % of all invasive breast cancers. They tend to occur more frequently in younger women. Medullary carcinomas are found more commonly in carriers of BRCA 1 mutations, but not all BRCA1 mutation-related cancers are likely to be medullary cancers.
openaire +1 more source
Wiener klinische Wochenschrift, 1983
This paper attempts to review current opinions on medullary thyroid carcinoma. Histologically described for the first time in 1951 belongs to the endocrine-secreting group of tumours (APUD). It can be sporadic as well as hereditary. The histological classification nowadays is increasingly performed immunohistologically via calcitonin.
K, Keminger, R, Kokoschka, E, Schmalzer
openaire +1 more source
This paper attempts to review current opinions on medullary thyroid carcinoma. Histologically described for the first time in 1951 belongs to the endocrine-secreting group of tumours (APUD). It can be sporadic as well as hereditary. The histological classification nowadays is increasingly performed immunohistologically via calcitonin.
K, Keminger, R, Kokoschka, E, Schmalzer
openaire +1 more source
[Medullary cancer of the thyroid].
La Revue du praticien, 1997Although rare (10% of thyroid cancers), medullary thyroid cancer is remarkable by the presence of a specific biological marker; elevation of blood calcitonin. It allows its preoperative diagnosis and this extensive surgery which is the only efficient treatment.
openaire +2 more sources